Cargando…

Anti-PD-1 Monotherapy in Advanced Melanoma—Real-World Data from a 77-Month-Long Retrospective Observational Study

Real-world evidence plays an important role in the assessment of efficacy and safety of novel therapies. The increasing use of immune checkpoint inhibitors (ICIs) in patients with advanced melanoma has led to notably improved clinical outcomes, while they are also associated with immune-related adve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuzmanovszki, Daniella, Kiss, Norbert, Tóth, Béla, Kerner, Tünde, Tóth, Veronika, Szakonyi, József, Lőrincz, Kende, Hársing, Judit, Imrédi, Eleonóra, Pfund, Alexa, Szabó, Ákos, Brodszky, Valentin, Rencz, Fanni, Holló, Péter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313334/ https://www.ncbi.nlm.nih.gov/pubmed/35885042 http://dx.doi.org/10.3390/biomedicines10071737

Ejemplares similares

Real-World Experience with Cemiplimab Treatment for Advanced Cutaneous Squamous Cell Carcinoma—A Retrospective Single-Center Study
por: Kuzmanovszki, Daniella, et al.
Publicado: (2023)

Cutaneous malignancies in patients with Parkinson’s disease at a dermato-oncological university centre in Hungary
por: Tóth, Veronika, et al.
Publicado: (2023)

Impact of Interleukin-17 Inhibitor Therapy on Arterial Intima-media Thickness among Severe Psoriatic Patients
por: Piros, Éva Anna, et al.
Publicado: (2021)

Anti-Interleukin-17 Therapy of Severe Psoriatic Patients Results in an Improvement of Serum Lipid and Inflammatory Parameters’ Levels, but Has No Effect on Body Composition Parameters
por: Piros, Éva Anna, et al.
Publicado: (2021)

Antidrug antibody formation during tumor necrosis factor α inhibitor treatment of severe psoriatic patients in the real-life practice
por: Herszényi, Krisztina, et al.
Publicado: (2019)

Immunohistochemical Study of the PD-1/PD-L1 Pathway in Cutaneous Lupus Erythematosus
por: Király, Zsófia, et al.
Publicado: (2022)

A Rasch model analysis of two interpretations of ‘not relevant’ responses on the Dermatology Life Quality Index (DLQI)
por: Rencz, Fanni, et al.
Publicado: (2021)

STIs during the COVID-19 Pandemic in Hungary: Gonorrhea as a Potential Indicator of Sexual Behavior
por: Lőrincz, Kende, et al.
Publicado: (2022)

Frequent KIT mutations in skin lesions of patients with BRAF wild-type Langerhans cell histiocytosis
por: Tóth, Béla, et al.
Publicado: (2020)

Is the trend of increasing use of patient-reported outcome measures in medical device studies the sign of shift towards value-based purchasing in Europe?
por: Weszl, Miklós, et al.
Publicado: (2019)

Assessment of health state utilities in dermatology: an experimental time trade-off value set for the dermatology life quality index
por: Ruzsa, Gábor, et al.
Publicado: (2022)

Validity and reliability of the 9-item Shared Decision Making Questionnaire (SDM-Q-9) in a national survey in Hungary
por: Rencz, Fanni, et al.
Publicado: (2019)

General and Skin-Specific Health-Related Quality of Life in Patients With Atopic Dermatitis Before and During the COVID-19 Pandemic
por: Koszorú, Kamilla, et al.
Publicado: (2022)

Measurement properties of the ICECAP-A capability well-being instrument among dermatological patients
por: Rencz, Fanni, et al.
Publicado: (2021)

A head-to-head comparison of the EQ-5D-5L and 15D descriptive systems and index values in a general population sample
por: Nikl, Anna, et al.
Publicado: (2023)

The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa
por: Bató, Alex, et al.
Publicado: (2021)

The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries
por: Gulácsi, László, et al.
Publicado: (2017)

Erratum to: The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries
por: Gulácsi, László, et al.
Publicado: (2017)

Hungarian PROMIS-29+2: psychometric properties and population reference values
por: Jenei, Balázs, et al.
Publicado: (2023)

Determinants of the acceptability of health problems in different ages: exploring a new application of the EQ VAS
por: Zrubka, Zsombor, et al.
Publicado: (2019)

Health utilities and willingness to pay in adult patients with coeliac disease in Hungary
por: Angyal, M. Mercédesz, et al.
Publicado: (2023)

Value Set for the EQ-5D-Y-3L in Hungary
por: Rencz, Fanni, et al.
Publicado: (2022)

Optically Guided High-Frequency Ultrasound to Differentiate High-Risk Basal Cell Carcinoma Subtypes: A Single-Centre Prospective Study
por: Bozsányi, Szabolcs, et al.
Publicado: (2023)

Subjective well-being in patients with pemphigus: a path analysis
por: Mitev, Ariel, et al.
Publicado: (2019)

Capability of well-being: validation of the Hungarian version of the ICECAP-A and ICECAP-O questionnaires and population normative data
por: Baji, Petra, et al.
Publicado: (2020)

Development the societal preference-based utility value set for the Patient Health Questionnaire depression scale in Hungary
por: Balázs, P., et al.
Publicado: (2022)

Cost-of-illness studies in nine Central and Eastern European countries
por: Brodszky, Valentin, et al.
Publicado: (2019)

Towards a Central-Eastern European EQ-5D-3L population norm: comparing data from Hungarian, Polish and Slovenian population studies
por: Zrubka, Zsombor, et al.
Publicado: (2019)

Determinants of biological drug survival in rheumatoid arthritis: evidence from a Hungarian rheumatology center over 8 years of retrospective data
por: Brodszky, Valentin, et al.
Publicado: (2017)

Subjective expectations regarding ageing: a cross-sectional online population survey in Hungary
por: Péntek, Márta, et al.
Publicado: (2019)

Scrofuloderma and granuloma annulare-like lesions: Challenges of diagnosing cutaneous tuberculosis in developed countries
por: Bánvölgyi, András, et al.
Publicado: (2023)

Acceptable health and ageing: results of a cross-sectional study from Hungary
por: Péntek, Márta, et al.
Publicado: (2020)

Emergency Use and Efficacy of an Asynchronous Teledermatology System as a Novel Tool for Early Diagnosis of Skin Cancer during the First Wave of COVID-19 Pandemic
por: Jobbágy, Antal, et al.
Publicado: (2022)

Societal costs and health related quality of life in adult atopic dermatitis
por: Beretzky, Zsuzsanna, et al.
Publicado: (2023)

Subjective health expectations of patients with age-related macular degeneration treated with antiVEGF drugs
por: Péntek, Márta, et al.
Publicado: (2017)

A comparison of European, Polish, Slovenian and British EQ-5D-3L value sets using a Hungarian sample of 18 chronic diseases
por: Zrubka, Zsombor, et al.
Publicado: (2019)

Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis
por: Koszorú, Kamilla, et al.
Publicado: (2022)

Population snapshot of the extended-spectrum β-lactamase-producing Escherichia coli invasive strains isolated from a Hungarian hospital
por: Tóth, Kinga, et al.
Publicado: (2022)

Complete Remission of Advanced Adrenocortical Cancer Following Mitotane Monotherapy: A Case Report and Literature Review of Predictive Markers
por: Tőke, Judit, et al.
Publicado: (2021)

Access to biologicals in Crohn’s disease in ten European countries
por: Péntek, Márta, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bd922a9arr1u3q6ev5ct4g94e8